Decreased BDNF levels in amygdala and hippocampus after intracerebroventricular administration of ouabain. Archives of Clinical Psychiatry, [S. l.], v. 39, n. 5, p. 157–160, 2012. DOI: 10.1590/S0101-60832012000500002. Disponível em: https://revistas.usp.br/acp/article/view/48310.. Acesso em: 4 may. 2024.